These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 22502720)

  • 21. HPV Testing With 16, 18, and 45 Genotyping Stratifies Cancer Risk for Women With Normal Cytology.
    Stoler MH; Wright TC; Parvu V; Yanson K; Eckert K; Kodsi S; Cooper C
    Am J Clin Pathol; 2019 Mar; 151(4):433-442. PubMed ID: 30649177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hybrid capture 2 assay based evaluation of high-risk HPV status in healthy women of north-east India.
    Rai AK; Das D; Kataki AC; Barmon D; Aggarwal D; Deka P; Shrivastava S; Sharma JD; Sarma A; Baruah U; Sharma M
    Asian Pac J Cancer Prev; 2014; 15(2):861-5. PubMed ID: 24568508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot study of HPV DNA and cytology testing in 50,159 women in the routine Mexican Social Security Program.
    Lazcano-Ponce E; Lörincz AT; Salmerón J; Fernández I; Cruz A; Hernández P; Mejia I; Hernández-Avila M
    Cancer Causes Control; 2010 Oct; 21(10):1693-700. PubMed ID: 20617376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
    Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
    BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.
    Flores Y; Shah K; Lazcano E; Hernández M; Bishai D; Ferris DG; Lörincz A; Hernández P; Salmerón J;
    Salud Publica Mex; 2002; 44(4):335-44. PubMed ID: 12216521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-risk human papillomavirus among HIV-infected women with normal cervical cytology: a pilot study in Jos, Nigeria.
    Musa J; Taiwo B; Achenbach C; Olugbenga S; Berzins B; Sagay AS; Idoko JA; Kanki PJ; Murphy RL
    Arch Gynecol Obstet; 2013 Dec; 288(6):1365-70. PubMed ID: 23700253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3.
    Rodríguez AC; Schiffman M; Herrero R; Hildesheim A; Bratti C; Sherman ME; Solomon D; Guillén D; Alfaro M; Morales J; Hutchinson M; Cheung L; Wacholder S; Burk RD
    Int J Cancer; 2012 Oct; 131(8):1874-81. PubMed ID: 22213126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Sequential Rounds of Cervical Cancer Screening on Management of HPV-positive Women: A 15-year Population-based Cohort Study from China.
    Xu XQ; Rezhake R; Hu SY; Chen F; Zhang X; Pan QJ; Zhang WH; Ma JF; Qiao YL; Zhao FH; Cruickshank M
    Cancer Prev Res (Phila); 2021 Mar; 14(3):363-372. PubMed ID: 33303694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human telomerase gene and high-risk human papillomavirus infection are related to cervical intraepithelial neoplasia.
    Zhao XY; Cui Y; Jiang SF; Liu KJ; Han HQ; Liu XS; Li Y
    Asian Pac J Cancer Prev; 2015; 16(2):693-7. PubMed ID: 25684510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prevalence of VAIN, CIN, and related HPV genotypes in Japanese women with abnormal cytology.
    Zhang S; Saito M; Yamada S; Sakamoto J; Takakura M; Takagi H; Sasagawa T
    J Med Virol; 2020 Mar; 92(3):364-371. PubMed ID: 31642536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia.
    Monsonego J; Pintos J; Semaille C; Beumont M; Dachez R; Zerat L; Bianchi A; Franco E
    Int J Gynecol Cancer; 2006; 16(2):591-8. PubMed ID: 16681731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical squamous cells of undetermined significance, human papillomavirus, and cervical intraepithelial neoplasia 2 or 3 in adolescents: ASC-US, age, and high-grade cervical neoplasia.
    Boardman LA; Weitzen S; Stanko C
    J Low Genit Tract Dis; 2006 Jul; 10(3):140-5. PubMed ID: 16829752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
    Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the HPV DNA test in follow-up of treated cervical intraepithelial neoplasia in Bangladesh.
    Nessa A; Rashid MH; Jahan M; Ferdous NE; Nahar PA; Chowdhury A
    Asian Pac J Cancer Prev; 2014; 15(19):8063-7. PubMed ID: 25338985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human Papillomavirus Co-Testing Results Effectively Triage Normal Cervical Cytology in HIV-Positive Women Aged 30 Years and Older.
    Alade RO; Vragovic O; Duffy C; Cabral HJ; Stier EA
    J Low Genit Tract Dis; 2017 Apr; 21(2):125-128. PubMed ID: 28257290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence characteristics of single and multiple HPV infections in women with cervical cancer and precancerous lesions in Beijing, China.
    Li M; Du X; Lu M; Zhang W; Sun Z; Li L; Ye M; Fan W; Jiang S; Liu A; Wang M; Meng Y; Li Y
    J Med Virol; 2019 Mar; 91(3):473-481. PubMed ID: 30281807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term observational approach in women with histological diagnosis of cervical low-grade squamous intraepithelial lesion: an Italian multicentric retrospective cohort study.
    Ciavattini A; Serri M; Di Giuseppe J; Liverani CA; Gardella B; Papiccio M; Delli Carpini G; Morini S; Clemente N; Sopracordevole F
    BMJ Open; 2019 Jul; 9(7):e024920. PubMed ID: 31272971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
    Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
    [No Abstract]   [Full Text] [Related]  

  • 39. Subtype distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia stages 2 and 3 in Botswana.
    Ramogola-Masire D; McGrath CM; Barnhart KT; Friedman HM; Zetola NM
    Int J Gynecol Pathol; 2011 Nov; 30(6):591-6. PubMed ID: 21979597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-Results from the Hammersmith study.
    Cuzick J; Szarewski A; Mesher D; Cadman L; Austin J; Perryman K; Ho L; Terry G; Sasieni P; Dina R; Soutter WP
    Int J Cancer; 2008 May; 122(10):2294-300. PubMed ID: 18240149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.